Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

This study has been completed.
Information provided by:
PRAECIS Pharmaceuticals Inc. Identifier:
First received: December 27, 2004
Last updated: September 18, 2006
Last verified: September 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given